Evidence map›Paper›PMID 41378299›Full record

ArticleFrontiers in oncology2025

Deep learning-based survival analysis of bladder cancer patients in the Putuo District, Shanghai, China.

Wang Ruojing, Shen Yuan, Shi Feiya, Yang Lijuan, Qin Yicen

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wang RuojingDepartment of Cancer Prevention and Systemic Regulation, Shanghai Putuo District Center for Disease Control and Prevention, Shanghai, China.
Shen YuanDepartment of Cancer Prevention and Systemic Regulation, Shanghai Putuo District Center for Disease Control and Prevention, Shanghai, China.
Shi FeiyaDepartment of Cancer Prevention and Systemic Regulation, Shanghai Putuo District Center for Disease Control and Prevention, Shanghai, China.
Yang LijuanDepartment of Cancer Prevention and Systemic Regulation, Shanghai Putuo District Center for Disease Control and Prevention, Shanghai, China.
Qin YicenDepartment of Cancer Prevention and Systemic Regulation, Shanghai Putuo District Center for Disease Control and Prevention, Shanghai, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Bladder cancer poses significant health risks and necessitates effective public health management. Objective: To develop a deep-learning survival prediction model using TabNet and compare its performance with logistic regression. Methods: Data on bladder cancer patients were collected from the Putuo District subset of Shanghai Cancer Registration and Reporting System. A total of 620 patients were included, divided into a training cohort (n=434) and a validation cohort (n=186). Logistic regression analyses were conducted to identify risk factors, while the TabNet framework was used to develop a deep learning-based model. Model performance was evaluated using ROC curves, decision curve analysis, and calibration curves. Shapley Additive Explanations (SHAP) was applied to interpret feature importance. Results: Baseline characteristics showed no significant differences between the training and validation cohorts (P>0.05). The TabNet model demonstrated high discriminative ability in predicting both 5-year OS and CSS within the training cohort, with net benefits surpassing those of logistic regression, and showed good calibration. In the validation cohort, the TabNet model exhibited excellent performance in predicting 5-year OS and CSS. SHAP analysis revealed that age, T stage, and N stage were the most influential factors. Conclusion: The TabNet model showed robust performance in predicting bladder cancer survival, offering valuable insights for community-based management and follow-up strategies.

Indexed as

5-yearbladder cancerdeep learninglogistic regressionsurvival

Identifiers

PMID41378299
PMCPMC12685632

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.